US 2021/0228546 A1Published application

Methods of treating malignant lymphoproliferative disorders

AssigneeActuate Therapeutics Inc.

InventorsFrancis GILES, Andrew MAZAR

Life of this patent

Estimating the term…

Abstract

Methods of treating malignant lymphoproliferative disorders in a patient, comprising administering an effective amount of a GSK-3β inhibitor, for example 9-ING41, are provided. Also provided are r s for treating malignant lymphoproliferative disorders comprising administering a ({umlaut over (ι)}8K-3β inhibitor, for example 9-ING-41, in combination with a second or multiple therapeutic agents.

Claims29

Dependent claims

A method of treating a malignant lymphoproliferative disorder in a patient in need thereof, comprising administering to said patient an effective amount of a GSK-3β inhibitor.

Dependencies are inferred from the claim text.

Facts

Application: 15/734,699Filed 5 Jun 2019
Priority: 5 Jun 2018
Published: 29 Jul 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 31/407
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: condensed with other…
A61K 31/433
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thidiazoles
A61K 31/52
Ortho- or peri-condensed with heterocyclic rings: purines, e.g. adenine
A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…

Family

Application62/680,739Us provisional application · filed 5 Jun 2018
US 11,510,904 B2Related patent
US 2021/0228546 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results